Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension

Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension

Abstract Pulmonary arterial hypertension (PAH) is a life‐threatening disease characterized by vasoconstriction and remodeling of the pulmonary vessels. Risk stratification in PAH could potentially be improved by including novel biomarkers related to PAH pathobiology. We aimed to investigate the rela...

Full description

Bibliographic Details
Main Authors: Mattias Arvidsson, Abdulla Ahmed, Joanna Säleby, Roger Hesselstrand, Göran Rådegran
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Pulmonary Circulation
Subjects:
extracellular matrix
matrix metalloproteinase‐2
prognosis
pulmonary arterial hypertension
risk assessment
Online Access:https://doi.org/10.1002/pul2.12041

Similar Items

Similar Items